Article Details

AB Science announces a voluntary hold in the clinical studies of masitinib worldwide

Retrieved on: 2021-06-01 05:03:45

Tags for this article:

Click the tags to see associated articles and topics

AB Science announces a voluntary hold in the clinical studies of masitinib worldwide. View article details on hiswai:

Excerpt

Founded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization of protein kinase ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up